Literature DB >> 17691900

Targeting carcinogen metabolism by dietary cancer preventive compounds.

Siwang Yu1, Ah-Ng Kong.   

Abstract

Prevention is one of the most important and promising strategies to control cancer. Many dietary bioactive compounds, mostly phytochemicals, have been found to decrease the risk of carcinogenesis. Modulating the metabolism and disposition pathways of carcinogens represents one of the major mechanisms by which dietary compounds prevent carcinogenesis. In the present review, the specific molecular targets of dietary compounds within carcinogen metabolism, including various enzymes and transporters and their regulatory signaling pathways, are briefly reviewed. The expression of phase I enzymes, which presumably mostly activate carcinogens, is mainly regulated by xenobiotics sensing nuclear receptors such as AhR, CAR, PXR, and RXR. On the other hand, phase II enzymes catalyze the conjugations of carcinogens and generally are transcriptionally controlled by the Nrf2/ARE signaling pathways. The Nrf2/ARE signaling pathway, which regulates the expression of many detoxifying enzymes, is a major target of dietary compounds. The final excretion of carcinogens and their metabolites is mediated by phase III transporters, which share many regulatory mechanisms with phase I/II enzymes. Indeed, the expression of metabolizing enzymes and transporters is often coordinately regulated. Besides transcriptional regulation, the activities of phase I/II enzymes and phase III transporters could be directly activated or inhibited by dietary compounds. Furthermore, genetic polymorphisms have profound effects on the individual response to dietary compounds. Finally, the effects of cancer prevention and the risk of carcinogenesis are determined by the network composed of known/unknown molecular targets and signaling pathways and its interaction with various xenobiotics, including carcinogens, drugs, and diet. With the rapid advances in the post genomic sciences, it could be possible to decipher this network and better predict the clinical outcomes of cancer prevention by dietary bioactive compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691900     DOI: 10.2174/156800907781386669

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  20 in total

1.  MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.

Authors:  Muhua Yang; Yuan Yao; Gabriel Eades; Yongshu Zhang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

Review 2.  Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer.

Authors:  Constance Lay Lay Saw; Ah-Ng Tony Kong
Journal:  Expert Opin Ther Targets       Date:  2011-01-25       Impact factor: 6.902

3.  High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.

Authors:  Yoshitaka Sekine; David Osei-Hwedieh; Kant Matsuda; Nalini Raghavachari; Delong Liu; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley
Journal:  Prostate       Date:  2011-03-03       Impact factor: 4.104

4.  Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates.

Authors:  Constance Lay-Lay Saw; Melvilí Cintrón; Tien-Yuan Wu; Yue Guo; Ying Huang; Woo-Sik Jeong; Ah-Ng Tony Kong
Journal:  Biopharm Drug Dispos       Date:  2011-06-08       Impact factor: 1.627

Review 5.  Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.

Authors:  Rong Hu; Constance Lay-Lay Saw; Rong Yu; Ah-Ng Tony Kong
Journal:  Antioxid Redox Signal       Date:  2010-08-17       Impact factor: 8.401

6.  Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.

Authors:  Tin Oo Khor; Francisco Fuentes; Limin Shu; Ximena Paredes-Gonzalez; Anne Yuqing Yang; Yue Liu; Dominic J Smiraglia; Srinivasan Yegnasubramanian; William G Nelson; Ah-Ng Tony Kong
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-29

7.  miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.

Authors:  Gabriel Eades; Muhua Yang; Yuan Yao; Yongshu Zhang; Qun Zhou
Journal:  J Biol Chem       Date:  2011-09-16       Impact factor: 5.157

8.  NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity.

Authors:  Yongshu Zhang; Jixiang Xia; Qinglin Li; Yuan Yao; Gabriel Eades; Ramkishore Gernapudi; Nadire Duru; Thomas W Kensler; Qun Zhou
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

Review 9.  A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics.

Authors:  Zheng-Yuan Su; Limin Shu; Tin Oo Khor; Jong Hun Lee; Francisco Fuentes; Ah-Ng Tony Kong
Journal:  Top Curr Chem       Date:  2013

10.  Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.

Authors:  Siwang Yu; Tin Oo Khor; Ka-Lung Cheung; Wenge Li; Tien-Yuan Wu; Ying Huang; Barbara A Foster; Yuet Wai Kan; Ah-Ng Kong
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.